Coagulase-negative staphylococci (CNS) are opportunistic pathogens which can cause disease in a variety of clinical situations. Staphylococcus epidermidis is the most frequent CNS isolated from these infections (1-5, 11, 12, 14, 15) . Staphylococcus saprophyticus is another significant pathogen frequently isolated from the urine of outpatient women (6, 11, 12) .
Until recently, the method of Kloos and Schleifer (7) was the only simple method available to identify the CNS. This method uses several different reagents and media and requires up to 72 h of incubation, which limits its application in the routine clinical laboratory. Nicolle et. al. (12) recommended the use of novobiocin susceptibility testing as a simplified screen to identify S. saprophyticus. Other CNS, however, are resistant to novobiocin (7, 12, 15) . This study evaluated two commercially available rapid identification systems which could be easily used in clinical microbiology laboratories to identify the CNS.
MATERIALS AND METHODS
Bacterial strains. The CNS tested included 157 blood isolates from 120 patients and 33 urine isolates which were in pure culture at >105 CFU/ml from 30 patients.
All isolates were frozen in buffered glycerol broth at -70°C. Before testing, the frozen isolates were subcultured three times on 5% sheep blood agar, and each was assigned a code number to ensure blind testing.
The following strains from the American Type Culture Collection, Rockville, Md. (ATCC) were (7) with the modification of Kloos and Wolfshohl (9) as our reference standard. Anaerobic growth in thioglycolate medium and phosphatase activity were not tested. The above procedures were modified as described below.
Coagulase. All tube coagulase tests were observed after 4 h of incubation at 35°C and after overnight incubation at room temperature (10) .
Hemolysis. Four 2 to 3-cm streaks were radially inoculated onto each plate of 5% citrated human blood in P agar (8) .
Nitrate reduction. Isolates were inoculated into 10 ml of nitrate broth (Difco Laboratories, Detroit, Mich.) and were incubated for 48 h in a non-CO, incubator at 35°C.
Novobiocin susceptibility. Half of a P agar plate was swabbed with an organism suspension equivalent to a 0.5 McFarland standard, and a 5-,ug novobiocin disk (BBL) was placed on the inoculated area (14) .
Carbohydrate The instructions of the manufacturer for strip inoculation, incubation, and reading were followed. After overnight incubation on sheep blood agar, test organisms were removed with a cotton swab and emulsified in 2 ml of 0.85% saline to obtain an inoculum density equivalent to a no. 3 McFarland standard. Each microcupule was inoculated with 2 drops of the organism suspension and incubated for 5 h in a non-CO2, 35°C incubator. After incubation, the strips were read according to the guidelines of the manufacturer. Two drops of Staph-Ident reagent were added to the fgalactosidase microcupule, and the reaction was read after 30 s. Reactions were scored to produce a fourdigit profile number, and the Staph-Ident profile register was consulted for the identification.
All identifications that matched the reference standard were scored as correctly identified. If the identification profile number deserved a rating of excellent, very good, or acceptable, the first identification choice was accepted. Any identification, with a rating of good likelihood, low selectivity was scored as not separated if the correct identification was listed as one of the identification choices.
AMS GPI card. The AutoMicrobic System (AMS) During incubation in the reader-incubator module, the computer automatically analyzed the reactions of the GPI card, and the data terminal subsequently printed the organism identification. Identification of each organism was accompanied by a percent probability for the accuracy of the identification. Because the manufacturer does not recommend a percent probability at which identifications are accepted or rejected, a correct identification was scored if the GPI identification matched the conventional identification regardless of the percent probability. A correct identification was also scored if the GPI card identified an organism not in the AMS data base as a Staphylococcus species or an unidentified organism. Any disagreements among the systems were repeated on all three systems with fresh overnight growth from sheep blood agar.
RESULTS
The predominant CNS isolate from the 190 blood and urine specimens was S. epidermidis. S. epidermidis accounted for 125 (79.6%) of the 157 blood isolates and for 20 (60.6%) of the 33 urine isolates. S. saprophyticus was isolated from 9 (27.4%) of the 33 urine specimens, whereas all other species were isolated from <5% of the blood and urine specimens. Five isolates not identified by the reference method were combined into a group consisting of S. hominis, S. haemolyticus, Staphylococcus warneri. Other investigators have also had some difficulty distinguishing S. hominis, S. haemolyticus, and S. warneri by the identification scheme of Kloos and Schleifer (3, 9) .
The GPI card correctly identified 158 (83.2%) of the 190 CNS isolates and 139 (95.9%) of the 145 S. epidermidis isolates ( Table 1 ). The GPI card correctly identified only 20 (40.4%) of the 45 other CNS; however, all 9 S. saprophyticus isolates were correctly identified. Four (2.1%) of the 190 CNS isolates required further testing for complete identification. Of the species that are not included in the AMS data base (S. warneri, Staphylococcus capitis, S. cohnii, S. sciuri), the GPI card identified 7 of the 12 isolates as Staphylococcus spp. or as an unidentified organism ( Table 2) .
Of the 139 S. epidermidis correctly identified by the GPI card, the identification percent probability was .90% for 129 (92.8%) and .80% for (Table 1 ) and listed the correct recommended by the API Staph-Ident proidentification as one of the identification choices file register (Table 4 ). All S. epidermidis isolates for an additional 59 (31.1%) isolates (Table 3) . requiring further testing had negative phosphaThe Staph-Ident correctly identified 108 tase reactions, but none of these isolates was (74.5%) of the S. epidermidis isolates without identified with the recommended differential further testing and listed S. epidermidis as an tests. Of the six S. saprophyticus isolates identi- The GPI card identified all nine S. saprophyticus isolates correctly, but eight other CNS were identified as S. saprophyticus. Only one misidentification had a percent probability of .80%. Therefore, S. saprophyticus misidentifications could also be resolved by only accepting identifications with a percent probability of .80% and by testing for novobiocin susceptibility.
The GPI card had difficulty identifying the other CNS which are in its data base, namely, S. haemolyticus, S. hominis, and S. simulans. The identification capability of the API Staph-Ident without supplemental testing was low because many of the profile numbers generated were not unique for a single species; that is, they earned a rating of good likelihood, low selectivity. All of the S. epidermidis that required further testing had negative phosphatase reactions. If the phosphatase reaction had been positive, the profile number would have been unique for that species, i.e., an identification rating of excellent. In contrast, Kloos and Wolfshohl (9) reported that 85 to 90% of the profile numbers of their isolates were unique for a single species; phosphatase-negative S. epiderinidis occurred less frequently in their study (ca. 7%, compared with 24.8% in this study). The API Staph-Ident data base needs to include phosphatase-negative S. epidermidis so that supplemental testing will not be necessary. Supplemental testing reduces the advantage of rapid reporting if one must wait 24 to 48 h for a more definitive result.
The Staph-Ident profile register needs to include more definitive tests to differentiate among the identification choices when a profile number is not unique for one species. Only 12 of the 57 isolates that required further testing were differentiated by the recommended tests. None of the S. epidermidis could be separated from the other choices by the recommended supplemental tests. However, Kloos and Wolfshohl found that when supplemental novobiocin and coagulase testing as recommended by the manufacturer were added, 95 to 96% of the profiles generated were unique (9) . The higher number of phosphatase-negative S. epidermidis in this study accounts for the lower percentage of isolates identified by the Staph-Ident. If the StaphIdent profile register is not expanded to include more definitive tests, the clinical laboratory would have to include its own further differential tests, such as anaerobic growth in a thioglycolate medium to differentiate phosphatase-negative S. epidermidis from S. hominis (9) .
The Staph-Ident must be visually interpreted by the technologist, which adds variability to the system. The phosphatase, ,-glucosidase, and P-glucuronidase wells contain chromogenic substrates, and the reactions are detected by the liberation of p-nitrophenol from the substrates. The phosphatase and ,B-glucosidase reactions were difficult to interpret because the difference between a positive and negative reaction was a subtle degree of yellow. In addition, the interpretation of the sugar utilization reactions required experience in differentiating the positive yellow-orange reactions from the negative orange reactions.
The AMS GPI card and API Staph-Ident are two commercially available products for the identification of the CNS. To select one of these two rapid methods for identification of the CNS, the advantages and disadvantages of each system must be considered.
The advantages of API Staph-Ident are that (i) it is easy to inoculate, (ii) the data base includes 13 Staphylococcus spp., and (iii) no special equipment is required. The disadvantages are that (i) the color reactions are difficult to interpret, (ii) the profile register must be expanded to include more definitive tests for identification, and (iii) the heavy inoculum density required may prevent same-day identification if the primary isolation plate has insufficient growth.
The advantages of the AMS GPI card are that (i) the card is automatically read and interpreted, (ii) supplemental testing is rarely necessary, (iii) a small inoculum is required, and (iv) no additional reagents are needed. The disadvantages are that (i) the data base includes only six Staphylococcus spp., (ii) the GPI card requires a multistep inoculation procedure, (iii) the AMS is a multicomponent system which requires extra laboratory space, and (iv) the initial cost of the instrument is substantial, although the AMS system offers other identification and susceptibility capabilities to help justify the initial cost.
